55 Biggest Movers From Friday
Gainers
Takung Art Co., Ltd. (NASDAQ: TKAT) surged 61.8% to close at $3.64 on Friday.
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that moved stocks during the week.
Clovis Oncology’s Rubraca Significantly Improves PFS In Ovarian Cancer Regardless Of Biomarker Status
Clovis Oncology Inc (NASDAQ:CLVS) announced positive topline data from the monotherapy arm of Phase 3 ATHENA-MONO trial of Rubraca (Rucaparib) as…
Clovis Oncology Highlights Ongoing Phase 1/2 LuMIERE Clinical Study And Multi-Tumor Imaging Investigator-Initiated Trial Of FAP-2286 Fibroblast Activation Protein-Targeted Radiotherapy Candidate At An Upcoming Nuclear Medicine Meeting
Clovis Oncology, Inc. (NASDAQ:CLVS) today announced a Trial-in-Progress poster detailing the Phase 1 portion of the LuMIERE clinical study for its targeted radiotherapy candidate FAP-2286 and a presentation titled
Recap: Clovis Oncology Q4 Earnings
Clovis Oncology (NASDAQ:CLVS) reported its Q4 earnings results on Wednesday, February 23, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.